BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide
Biopharmaceutical classification system (BCS) class IV drugs (low-solubility low-permeability) are generally poor drug candidates, yet, ~5% of oral drugs on the market belong to this class. While solubility is often predictable, intestinal permeability is rather complicated and highly dependent on m...
Saved in:
Main Authors: | Milica Markovic (Author), Moran Zur (Author), Inna Ragatsky (Author), Sandra Cvijić (Author), Arik Dahan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil
by: Milica Markovic, et al.
Published: (2022) -
Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development
by: Milica Markovic, et al.
Published: (2020) -
Optimized In Silico Modeling of Drug Absorption after Gastric Bypass: The Case of Metformin
by: Arik Dahan, et al.
Published: (2021) -
Regional Intestinal Drug Absorption: Biopharmaceutics and Drug Formulation
by: Arik Dahan, et al.
Published: (2021) -
Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on in vivo data from intestinal perfusion models
by: David Dahlgren, et al.
Published: (2020)